65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04887311
(ClinicalTrials.gov)
July 20215/5/2021MBM-01 (Tempol) for the Treatment of Ataxia TelangiectasiaAn Open Label Study to Assess the Safety and Efficacy of MBM-01 for the Treatment of Ataxia TelangiectasiaAtaxia Telangiectasia Louis-Bar;Ataxia Telangiectasia in Children;Ataxia TelangiectasiaDrug: MBM-01Matrix Biomed, Inc.The University of Texas Health Science Center, HoustonNot yet recruiting4 YearsN/AAll20Phase 2United States